1
Back
Expert Opinion on Drug Discovery cover

Expert Opinion on Drug Discovery

IF4.9
Papers2153
Citations6668
Journal Papers 2137
Publication Date
delete
Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-19
delete0
PREAI
deleteSanaz Sabzehei; Nicole Innocenti; Marta Rigoli; Jesús R. Requena; Emiliano Biasini
deleteShare
deleteSave
The root cause: why do so many drugs fail to translate from bench to bedside?
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-18
delete0
deleteOAAI
deleteAndre Levchenko; Mark Corrigan; Bruce Wexler
deleteShare
deleteSave
Epigenetic reactivation in Friedreich’s ataxia from benzamides to gene‑targeted chimeras
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-16
delete0
PREAI
deleteFaizan U. Ansari; Teerapat Rojsajjakul; Jiayi Liu; Sathiji K. Nageshwaran; Ian A. Blair
deleteShare
deleteSave
The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-15
delete0
PREAI
deleteTadeusz Robak; Paweł Robak
deleteShare
deleteSave
“Too soon to tell”? The potential of tools like AggrescanAI for novel drug discovery and development
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-09
delete0
deleteOAAI
deleteCristina Marino-Buslje; Salvador Ventura
deleteShare
deleteSave
Moving forward with molecular skeleton editing (MSE) for new drug discovery: where to next?
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-07
delete0
PREAI
deleteAnthony J. Burke; Carolina S. Marques
deleteShare
deleteSave
Preclinical discovery and clinical development of glofitamab in relapsed/ refractory large B-cell lymphomas
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-07
delete0
PREAI
deletePhilipp Berning; Gilles Salles
deleteShare
deleteSave
Building tomorrow’s medicines: how robotic synthesis is actualizing AI’s drug discovery promise
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-06-07
delete0
deleteOAAI
deleteDinesh Kumar
deleteShare
deleteSave
High-throughput screening assays for novel antibacterial identification: current advances and future prospects
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-31
delete0
deleteOAAI
deleteHolly E. E. Floyd; Michelle Novais de Paula; Tanuka Sen; Angela M. Kavanagh; Johannes Zuegg; Mark A. T. Blaskovich
deleteShare
deleteSave
The design and discovery of topoisomerase-II inhibitors as new cancer drugs: current strategies and future perspectives
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-25
delete0
PREAI
deletePrasanna Anjaneyulu Yakkala; Rahaman Shaik; Bhusi Reddy Seelam; Divya Vohora; Vijjulatha Manga; Ahmed Kamal
deleteShare
deleteSave
Animal models that mirror bipolar disorder’s pathophysiologic complexities: focused review of common models
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-22
delete0
PREAI
deleteRamy Yassa; Muhammad Ibrahim; Rif S. El-Mallakh
deleteShare
deleteSave
Artificial intelligence in antimicrobial drug discovery: predictive and generative strategies
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-19
delete0
PREAI
deleteXimeng Duan; Na Liu; Lin Liu; Wei Geng; Dongmei Tan; Lin Liu; Hongxiang Lou; Xiuyun Li
deleteShare
deleteSave
The design of multi-target ligands and their role in schizophrenia therapy: an update
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-08
delete0
PREAI
deleteZarko Gagic; Marija Popovic-Nikolic; Marija Carapic; Selma Zukic; Slavica Oljacic; Katarina Nikolic
deleteShare
deleteSave
The application of fluorinated α-amino acids to drug discovery techniques
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-06
delete0
PREAI
deletePaul Richardson
deleteShare
deleteSave
Multi-target approaches to prion disease drug discovery: a status update
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-05
delete0
PREAI
deleteLea Nikolić; Giuseppe Legname
deleteShare
deleteSave
In vitro prediction of the immunogenicity of therapeutic proteins: state of the art and current challenges and perspectives
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-05-04
delete0
PREAI
deleteOlivier Fardel; Emna Mahfoudhi; Laurence Launay; Amélie Moreau; Claire Denizot; David Malnoë; Yannick Parmentier
deleteShare
deleteSave
Therapeutic targeting of adhesion GPCRs: a status update and future potential
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-04-24
delete0
PREAI
deleteJesse D. Stillwell; Maryam Ahmadian Elmi; Rashed R. Parag; Erwin G. Van Meir
deleteShare
deleteSave
Leveraging machine learning for selective cannabinoid ligand discovery: methods, challenges, and opportunities
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-04-21
delete0
PREAI
deleteBailang Liu; Jie Liu; Wenjing Guo; Ann Varghese; Menghang Xia; Ruili Huang; Tucker A. Patterson; Huixiao Hong
deleteShare
deleteSave
Advancing drug discovery for inflammatory bowel diseases through human intestinal organoid-based models
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-04-02
delete0
PREAI
deleteManuel B. Braga-Neto; Samreen Jatana; Florian Rieder; Andrei I. Ivanov
deleteShare
deleteSave
Therapeutic aptamers in drug discovery: future elements of the pharmaceutical arsenal?
deleteExpert Opinion on Drug Discovery
IF4.9
delete2026-04-02
delete0
deleteOAAI
deleteKrushna P. Dhorde; Ipsita Roy
deleteShare
deleteSave